Lungbank: a novel biorepository strategy tailored for comprehensive multiomics analysis and p-medicine applications in lung cancer
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/12753/Boyac%c4%b1-%c4%b0hsan-2024.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Access
info:eu-repo/semantics/openAccessAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Date
2024Author
Demircan Çeker, DilekBaysungur, Volkan
Evman, Serdar
Kolbaş, İlker
Gördebil, Abdurrahim
Nalbantoğlu, Sinem M.
Tambağ, Yusuf
Kaçar, Ömer
Midi, Ahmet
Aslanoğlu, Hatice
Kara, Nülüfer
Algan, Nilgün
Boyacıoğlu, Ayberk
Karademir Yılmaz, Betül
Şahin, Ali
Ülbeği Polat, Hivda
Şehitoğullari, Abidin
Çibikdiken, Ali Osman
Büyükyılmaz, Mücahit
Aydilek, İbrahim Berkan
Eneş, Abdulkerim
Küçüker, Sevde
Karakaya, Fatih
Boyacı, İhsan
Gümüş, Mahmut
Şenol, Onur
Öztuğ, Merve
Şaban, Evren
Soysal, Ömer
Büyükpınarbaşılı, Nur
Turna, Akif
Günlüoğlu, Mehmet Zeki
Çakır, Aslı
Tekin, Şaban
Tazebay, Uygar
Karadağ, Abdullah
Metadata
Show full item recordCitation
Demircan Çeker, D., Baysungur, V., Evman, S., Kolbaş, İ., Gördebil, A., Nalbantoğlu, S. M. ... Karadağ, A. (2024). Lungbank: a novel biorepository strategy tailored for comprehensive multiomics analysis and p-medicine applications in lung cancer. Turkish Journal of Biology, 48(3). http://dx.doi.org/10.55730/1300-0152.2696Abstract
Background/aim: LUNGBANK was established as part of Project LUNGMARK, pioneering a biorepository dedicated exclusively to lung cancer research. It employs cutting-edge technologies to streamline the handling of biospecimens, ensuring the acquisition of high-quality samples. This infrastructure is fortified with robust data management capabilities, enabling seamless integration of diverse datasets. LUNGBANK functions not merely as a repository but as a sophisticated platform crucial for advancing lung cancer research, poised to facilitate significant discoveries. Materials and methods: LUNGBANK was meticulously designed to optimize every stage of biospecimen handling, from collection and storage to processing. Rigorous standard operating procedures and stringent quality control measures guarantee the integrity of collected biospecimens. Advanced data management protocols facilitate the efficient integration and analysis of various datasets, enhancing the depth and breadth of research possibilities in lung cancer. Results: LUNGBANK has amassed a comprehensive collection of biospecimens essential for unraveling the intricate molecular mechanisms of lung cancer. The integration of state -of -the -art technologies ensures the acquisition of top-tier data, fostering breakthroughs in translational and histological research. Moreover, the establishment of patient-derived systems by LUNGBANK underscores its pivotal role in personalized medicine approaches. Conclusion: The establishment of LUNGBANK marks a significant milestone in addressing the critical challenges of lung cancer research. By providing researchers with high-quality biospecimens and advanced research tools, LUNGBANK not only supports Project LUNGMARK's objectives but also contributes extensively to the broader landscape of personalized medicine. It promises to enhance our understanding of lung cancer initiation, progression, and therapeutic interventions tailored to individual patient needs, thereby advancing the field towards more effective diagnostic and therapeutic strategies.
WoS Q Kategorisi
Q3Source
Turkish Journal of BiologyVolume
48Issue
3Collections
- Makale Koleksiyonu [3790]
- PubMed İndeksli Yayınlar Koleksiyonu [4251]
- WoS İndeksli Yayınlar Koleksiyonu [6677]